Answers are grounded in this paper and cite their sources.
Objectives Iron deficiency is frequent among patients with systemic sclerosis (SSc), particularly among those with pulmonary hypertension (PH). First data indicate prognostic importance of hypochromic red cells (% HRC)>2% among patients with PH. Hence, the aim of this study was to investigate the prognostic value of% HRC in SSc patients screened for PH. Methods In this retrospective, single-centre cohort study SSc patients screened for PH were included. Clinical characteristics, laboratory and pulmonary functional parameters associated with the prognosis of SSc were analysed using uni- and multivariable analysis. Results A total of 280 SSc patients were screened, 171 were included in the analysis having complete data of iron metabolism (81% female, 60±13 years of age, 77% limited cutaneous SSc, 65 manifest PH and 73 pulmonary fibrosis). The patients were followed for 2.4±1.8 (median 2.4) years. HRC>2% at baseline was significantly associated with worse survival in the uni- (p=0.018) and multivariable analysis (p=0.031) independent from the presence of pulmonary manifestations. The combination of HRC>2% and low diffusion capacity for carbon monoxide (DLCO)≤65% predicted was significantly associated with mortality (p<0.0001). Conclusion This study detected for the first time that HRC>2% is an independent prognostic predictor of mortality and can possibly be used as a biomarker among SSc-patients. The combination of HRC>2% and DLCO≤65% predicted could serve in risk stratification of SSc patients. Further studies are needed to confirm these results. Publication History Article published online: 09 March 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Xanthouli et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: